Whether You Like Illumina or Not, Here Are 2 Trade Ideas Who do you think probably better understands this business... one of the very best analysts on the entire street or the FTC? Stocks quotes in this article: ILMN Before we get excited, Illumina (ILMN) does not report for another two and a half weeks. At least now we should not be surprised. We all had our eyes on one ball, in the air, while the juggler was actually doing amazing things with his hands just out of our sight. The story really begins back in September. Big news! Illumina, a firm focused on large scale analysis of genetic variation and biological function, which is huge right now for obvious reasons, to acquire GRAIL, a healthcare company more focused on the early detection of multiple cancer types in a cash and stock deal reportedly worth roughly $8 billion. The deal already had the approval of both boards involved.